Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation 2001; 72: 1399.
Khanna
A
A
D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D016219:Immunotherapy, Adoptive; D008232:Lymphoproliferative Disorders / Q000628:therapy*; D016377:Organ Transplantation / Q000009:adverse effects*; D011183:Postoperative Complications / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*